Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness.
The goal of a recent study [1] was to evaluate whether nebulized hypertonic saline (3%) was more beneficial than nebulized normal saline (0.9%) in the treatment of infants presenting to the emergency ...
March 10, 2003 (Denver) — Eight weeks of twice-daily treatment with large-particle nebulized saline (LPNS) appears to improve chronic nasal obstruction in patients dissatisfied with previous therapy, ...
Children with bronchiolitis (a common respiratory tract infection that can result in hospitalization) who were treated in the emergency department showed less clinical improvement after receiving ...
Bronchiolitis, a disorder in infants most commonly resulting from viral lower respiratory tract infection, is associated with acute inflammation, small airway involvement with epithelial cell necrosis ...
Please provide your email address to receive an email when new articles are posted on . DENVER — Hypertonic saline provides no additional benefit compared with normal saline for the treatment of ...
Queen's University Belfast-led research reports on a multicenter trial finding no significant reduction in pulmonary ...
Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...
As air quality declines and pollution levels rise, people become more vulnerable to allergies and respiratory conditions. For kids with allergies or any other respiratory condition, poor air quality ...
Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic saline solution inhibits replication of SARS-CoV-2, the virus that causes COVID-19, and have elucidated the ...
Bottom Line: Children with bronchiolitis (a common respiratory tract infection that can result in hospitalization) who were treated in the emergency department showed less clinical improvement after ...